BIOCURE TECHNOLOGY INC. Cash Flow-to-Debt Ratio
BIOCURE TECHNOLOGY INC. cash flow-to-debt ratio. BIOCURE TECHNOLOGY INC. (1WH) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of €-8.28K could theoretically repay 0% of its total liabilities (€435.01K) in one year. Check how aggressively does BIOCURE TECHNOLOGY INC. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BIOCURE TECHNOLOGY INC. (2021–2025)
Cash flow-to-debt ratio of BIOCURE TECHNOLOGY INC. from 2021 to 2025. Historical debt coverage capacity for BIOCURE TECHNOLOGY INC. across 5 annual periods. See net asset quality index of BIOCURE TECHNOLOGY INC. to measure how much of total assets are equity-financed.
BIOCURE TECHNOLOGY INC. Cash Flow-to-Debt Ratio by Year (2021–2025)
BIOCURE TECHNOLOGY INC. cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for BIOCURE TECHNOLOGY INC.. For the full cash flow conversion analysis, see BIOCURE TECHNOLOGY INC. cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | €-76.52K | €435.01K | ▼ -934.5% |
| 2024 | 0.02x | €13.71K | €650.57K | ▲ +103.6% |
| 2023 | -0.58x | €-217.13K | €373.24K | ▼ -213.6% |
| 2022 | -0.19x | €-818.38K | €4.41 Million | ▲ +14.3% |
| 2021 | -0.22x | €-1.08 Million | €5.01 Million | — |